Fused in sarcoma (FUS) is an RNA-binding protein involved in pathogenesis of several neurodegenerative dis-eases.AggregationofmislocalizedFUS intonon-amyloid inclusions isbelieved tobepivotal in thedevelopment of cell dysfunction, but themechanismof their formation is unclear. Using transient expression of a panel of de-letion and chimeric FUS variants in various cultured cells, we demonstrated that FUS accumulating in the cyto-plasmnucleates a novel type of RNAgranules, FUSgranules (FGs), that are structurally similar but not identical to physiological RNA transport granules. Formation of FGs requires FUS N-terminal prion-like domain and the ability to bind specific RNAs. Clustering of FGs coupled with further recruitment of RNA and protei...
Fused in sarcoma (FUS) is an RNA binding protein involved in regulating many aspects of RNA processi...
Dysfunction of two structurally and functionally related proteins, FUS and TAR DNA-binding protein o...
Purified recombinant FUsed in Sarcoma (FUS) assembles into an oligomeric state in an RNA-dependent m...
Fused in sarcoma (FUS) is an RNA-binding protein involved in pathogenesis of several neurodegenerati...
Fused in sarcoma (FUS) belongs to the group of RNA-binding proteins implicated as underlying factors...
The discovery of a causative link between dysfunction of a number of RNA-binding proteins with prion...
Amyotrophic lateral sclerosis (ALS) is an aggressive neurodegenerative disease characterised by the ...
Fused in sarcoma (FUS) is a DNA/RNA binding protein that is involved in RNA metabolism and DNA repai...
SummaryThe abundant nuclear RNA binding protein FUS binds the C-terminal domain (CTD) of RNA polymer...
The abundant nuclear RNA binding protein FUS binds the C-terminal domain (CTD) of RNA polymerase II ...
RNA-binding protein aggregation is a pathological hallmark of several neurodegenerative disorders, i...
Mutations to the RNA binding protein, fused in sarcoma (FUS) occur in ∼5% of familial ALS and FUS-po...
Subcellular mislocalization and aggregation of the human FUS protein occurs in neurons of patients w...
Fused in sarcoma (FUS) is an RNA binding protein involved in regulating many aspects of RNA processi...
Dysfunction of two structurally and functionally related proteins, FUS and TAR DNA-binding protein o...
Purified recombinant FUsed in Sarcoma (FUS) assembles into an oligomeric state in an RNA-dependent m...
Fused in sarcoma (FUS) is an RNA-binding protein involved in pathogenesis of several neurodegenerati...
Fused in sarcoma (FUS) belongs to the group of RNA-binding proteins implicated as underlying factors...
The discovery of a causative link between dysfunction of a number of RNA-binding proteins with prion...
Amyotrophic lateral sclerosis (ALS) is an aggressive neurodegenerative disease characterised by the ...
Fused in sarcoma (FUS) is a DNA/RNA binding protein that is involved in RNA metabolism and DNA repai...
SummaryThe abundant nuclear RNA binding protein FUS binds the C-terminal domain (CTD) of RNA polymer...
The abundant nuclear RNA binding protein FUS binds the C-terminal domain (CTD) of RNA polymerase II ...
RNA-binding protein aggregation is a pathological hallmark of several neurodegenerative disorders, i...
Mutations to the RNA binding protein, fused in sarcoma (FUS) occur in ∼5% of familial ALS and FUS-po...
Subcellular mislocalization and aggregation of the human FUS protein occurs in neurons of patients w...
Fused in sarcoma (FUS) is an RNA binding protein involved in regulating many aspects of RNA processi...
Dysfunction of two structurally and functionally related proteins, FUS and TAR DNA-binding protein o...
Purified recombinant FUsed in Sarcoma (FUS) assembles into an oligomeric state in an RNA-dependent m...